Feb 28, 2024
Dive into the dynamic world of Public Relations with this essential PR glossary. Tailored for you, the PR pro, it breaks down key terms...
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating La Jolla Pharmaceuticals Company Buyout
July 12, 2022 9:37 AM EDT | Source: Rigrodsky Law, P.A.
Wilmington, Delaware--(Newsfile Corp. - July 12, 2022) - Rigrodsky Law, P.A. is investigating La Jolla Pharmaceuticals Company ("La Jolla") (NASDAQ: LJPC) regarding possible breaches of fiduciary duties and other violations of law related to La Jolla's agreement to be acquired by Innoviva Inc. (NASDAQ: INVA). Under the terms of the agreement, La Jolla's shareholders will receive $6.23 in cash for each share of La Jolla common stock they own.
To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-la-jolla-pharmaceuticals-company.
To contact Seth D. Rigrodsky or Gina M. Serra cost free, call or text (302) 295-5310 or email info@rl-legal.com.
Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.
Attorney advertising. Prior results do not guarantee a similar outcome.
Contact:
Rigrodsky Law, P.A.
Seth D. Rigrodsky, Esq.
Gina M. Serra, Esq.
Call or Text: (302) 295-5310
Email: info@rl-legal.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/130660